Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$38.82 - $54.59 $31,521 - $44,327
-812 Reduced 4.43%
17,526 $709,000
Q4 2022

Feb 08, 2023

SELL
$40.77 - $53.73 $43,297 - $57,061
-1,062 Reduced 5.47%
18,338 $853,000
Q1 2022

May 11, 2022

BUY
$56.06 - $74.11 $294,819 - $389,744
5,259 Added 37.19%
19,400 $1.38 Million
Q4 2021

Feb 10, 2022

BUY
$60.19 - $97.37 $851,146 - $1.38 Million
14,141 New
14,141 $1.05 Million
Q3 2020

Nov 12, 2020

SELL
$43.36 - $53.53 $407,584 - $503,182
-9,400 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$46.37 - $57.58 $1.02 Million - $1.26 Million
-21,900 Reduced 69.97%
9,400 $472,000
Q1 2020

May 13, 2020

SELL
$40.22 - $62.0 $76,418 - $117,800
-1,900 Reduced 5.72%
31,300 $1.61 Million
Q4 2019

Feb 14, 2020

BUY
$57.95 - $66.61 $249,185 - $286,423
4,300 Added 14.88%
33,200 $2.05 Million
Q3 2019

Nov 08, 2019

BUY
$60.08 - $88.17 $294,392 - $432,033
4,900 Added 20.42%
28,900 $1.74 Million
Q2 2019

Aug 09, 2019

SELL
$81.3 - $97.35 $479,670 - $574,365
-5,900 Reduced 19.73%
24,000 $2.03 Million
Q1 2019

May 15, 2019

SELL
$69.08 - $105.66 $317,768 - $486,036
-4,600 Reduced 13.33%
29,900 $2.86 Million
Q4 2018

Feb 12, 2019

BUY
$65.41 - $84.65 $2.26 Million - $2.92 Million
34,500 New
34,500 $2.44 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.